Researchers from the Los Alamos National Laboratory in New Mexico and Duke University in North Carolina partnered with the University of Sheffield's COVID-19 Genomics UK research group to analyze genome samples published on GISAID, an international resource for sharing genome sequences....
Repurposing drugs like favipiravir, remdesivir, chloroquine, and TMPRSS2 protease inhibitors have been shown to be effective for the treatment of COVID-19. Personal protective measures should be followed to prevent SARS-CoV-2 infection. In addition, a clinical trial of SARS-CoV-2 vaccine, mRNA-...
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently was declared a pandemic by world health organization (WHO) Due to sudden outbreaks, currently, no completely effective vaccine or drug is clinically approved. Several therapeutic strategies ...
"If you look at the structure ofomicronand compare it to the structure of previous strains, including delta, the site where there is the most change from the original strain is the spike protein," says Dr. Andrew Badley, chair of Mayo Clinic's COVID-19 Task Force. That means current th...
In lab experiments using non-human primate cells, Kawaoka's team tested a suite of antibody and antiviral therapies against the original strain of the COVID-19 virus and its prominent variants, including the alpha, delta and omicron strains. ...
Zhiqiang Xiao3, Kaiyan Ye4, Xiaoen He2, Bo Sun1, Zhiran Qin2, Jianghai Yu2, Jinxiu Yao5, Qinghua Wu2, Zhang Bao2* and Wei Zhao2* Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has spread rapidly across the world and become an international public healt...
The pandemic created global economic strain, and LMIs experienced the brunt of it through increased debts and poorer health outcomes, especially with the negative impact on childhood vaccinations [51, 56]. COVID-19 mortality rates among children in LMIC have been low so far, but they face ...
Additional studies are certainly required to determine whether or not lopinavir/ritonavir treatment given at a certain stage of illness can reduce some COVID-19 complications. While already multiple other ongoing studies exploring lopinavir/ritonavir in SARS-CoV-2 infection are ongoing, none utilizes a...
On January 11, the United States reported a record-breaking 1.35 million new COVID-19 infections, shattering the previous record set just eight days before. The sky-high case rate—roughly four times higher than numbers of daily infections seen last January—are a testament to the transmissibilit...
With the outbreak of the new strain of the coronavirus (COVID-19), the severe measures to counter the spread of the virus led to unprecedented changes in the daily life of people all around the world. From spring 2020 onwards, in many countries all over the world general mobility was rest...